Pre-Conference Workshop Day

Tuesday | March 12, 2024

Event Live!

Workshop A

9:30 am - 12:00 am

Synergizing Formulation Strategy with Devices for Nasal Drug Delivery

Nasal drug-device compatibility can be challenging due to a combination of physiological, technical, and formulation-related factors.

Join us as we explore key topics, from deposition patterns to data-driven design approaches, and unlock the secrets to precise dosing accuracy in nasal drug delivery.

Take part in this workshop as we explore:

  • Reviewing formulation considerations with deposition pattern in mind to enhance targeted drug delivery within the nasal cavity
  • Learning how data-driven approaches empower precise formulation design, ensuring compatibility with nasal delivery devices and achieving desired dosing accuracy
  • Gaining insights into critical factors influencing actual dose, including actuation mechanisms, device selection (spray pump vs. meter-dose inhaler), and droplet size for effective drug dispersion and dosing strategy
John Marshall

John Marshall
Chief Scientific Officer
Beyond Barriers Therapeutics

 

Michael Palfreyman

Michael G. Palfreyman
President
Palfreyman BioPharm Advisors

 

Workshop B

1:00 pm - 3:00 pm 

Elevating Vaccine Efficacy & Durability with Optimized Nasal Delivery Systems

Optimizing nasal delivery systems for vaccines holds significant promise for improving
vaccine efficacy, accessibility, and durability. This approach has the potential to
revolutionize vaccination strategies.

Get involved as we delve into:

  • Understanding and addressing the unique challenges in developing nasal vaccines
    for enhanced immunogenicity
  • Exploring the flexibility of nasal delivery for various payload types, including genes, lipid nanoparticles, proteins, biopolymers, liposomes and antigens, to boost immune responses
  • Assessing strategies to ensure reliable transport and release, ensuring chemical
    and thermal stability of nasal vaccines
download (1)

Lillian Li
CMC, Product and
Device Lead

Sanofi Pasteur

Kapileswar Swain

Kapileswar Swain
Director and R&D Site Head Nasal, Inhalation, Opthalmic
Apotex